Ralf Sanzenbacher

Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

Thomas Lener, Mario Gimona, Ludwig Aigner et al. · Journal of Extracellular Vesicles · 2015 · 1.4K citations · Full text

International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19

Verena Börger, Daniel J. Weiss, Johnathon D. Anderson et al. · Cytotherapy · 2020 · 134 citations · Full text

Extracellular Vesicles, Translational Medicine, Gene Therapy Statement +8

SLP-76 Binding to p56 <i>lck</i> : A Role for SLP-76 in CD4-Induced Desensitization of the TCR/CD3 Signaling Complex

Ralf Sanzenbacher, Dieter Kabelitz · The Journal of Immunology · 1999 · 56 citations · Full text

Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor¹

Jennifer M. Wenzel, Ralf Sanzenbacher, Markus Philipp Ghadimi et al. · FEBS Letters · 2001 · 52 citations

Apoptosis, Immune Regulation, Immunology +23

Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178)¹

Markus Philipp Ghadimi, Ralf Sanzenbacher, Bernd Thiede et al. · FEBS Letters · 2002 · 51 citations

Apoptosis, Immunology, Interaction Partners +18